探讨儿童急性淋巴细胞白血病患者接受培门冬酶化疗后发生极重度高三酰甘油后的临床分析和治疗。

回顾分析1例接受培门冬酶化疗后发生血脂异常患者的临床资料及诊治过程。

检验师与临床医生沟通交流后，通过及时监测患者的血脂水平和使用降血脂药，让患者的血脂水平降至正常水平，引起临床对该类药物导致血脂显著升高这一不良反应的重视。

临床应关注培门冬酶化疗后引起的不良反应，定时监测患者的临床症状以及相关检验指标，避免患者发生高三酰甘油血症性急性胰腺炎，为患者的顺利治疗保驾护航。

To investigate the clinical analysis and treatment of severe hypertriglycerides in children with acute lymphoblastic leukemia following pegaspargase chemotherapy.

A retrospective analysis was conducted on the clinical data, diagnosis and treatment process of a patient with dyslipidemia after receiving chemotherapy with pegaspargase.

Through communication between the laboratory technician and clinician, timely monitoring of the patient's lipid levels and the administration of lipid-lowering medications successfully reduced the patient's lipid levels to normal. This case highlights the importance of clinical awareness of the significant elevation in lipid levels as an adverse reaction to this class of drugs.

Clinical attention should be paid to the adverse reactions caused by chemotherapy with pegaspargaseand the clinical symptoms and relevant test indicators of patients should be monitored regularly, avoid hypertriglyceridemic acute pancreatitis. This approach ensures smooth and effective treatment for patients, safeguarding their health and well-being.